CellRev

CellRev is a biotechnology startup based in the United Kingdom, founded in 2018. The company's slogan "Enabling access to life savings treatments" underscores its mission to revolutionize cell manufacturing. CellRev offers bioprocessing solutions that address critical bottlenecks in cell culture protocols, such as aggregation, clumping, cell detachment, and process translatability. Its innovative products, leveraging application specific IP, enable productivity and cost improvements in existing batch, fed-batch, and perfusion based bioprocesses. Notably, CellRev also introduced the Livit ACE, a pioneering continuous processing platform for adherent cells, recognized as a significant breakthrough in the industry.

In December 2023, CellRev secured a significant £330.00K grant investment from Innovate UK, a noteworthy achievement that attests to its potential and market recognition. With a focus on enabling breakthrough treatments from discovery to manufacturing, CellRev stands out as a promising player in the biotechnology sector, catering to the needs of a rapidly evolving industry. For those seeking tailored support in process development or enhancement, CellRev's expertise and solutions offer valuable opportunities for collaboration and advancement. For further inquiries, interested parties can reach out to the company at [email protected].